ModerateSynergy
Prednisone and other corticosteroids significantly deplete calcium through multiple mechanisms, increasing the risk of osteoporosis and fractures. Calcium supplementation is considered standard of care for patients on chronic corticosteroid therapy.
Recommendation: Take calcium (1000-1200mg/day in divided doses) with vitamin D while on chronic prednisone therapy. This is a guideline-recommended practice for preventing corticosteroid-induced osteoporosis. Use calcium citrate for better absorption.
ModerateSynergy
Prednisone impairs vitamin D metabolism and reduces its active form (calcitriol) production. This contributes to decreased calcium absorption and accelerated bone loss. Vitamin D supplementation is considered essential during chronic corticosteroid therapy to maintain bone health.
Recommendation: Take vitamin D3 (1000-2000 IU/day) while on chronic prednisone therapy. Higher doses may be needed based on serum 25-OH vitamin D levels. This is guideline-recommended for preventing corticosteroid-induced osteoporosis.
ModerateSynergy
Prednisone can promote potassium loss or potassium shifts in susceptible patients, especially at higher systemic doses, prolonged use, or when combined with other hypokalemia risks.
Recommendation: Monitor potassium when prednisone is high dose, prolonged, or combined with diuretics, vomiting, diarrhea, or heart-rhythm risk. Increase dietary potassium only if appropriate and use supplements only if labs/prescriber guidance support it.
ModerateSynergy
Prednisone causes zinc depletion through increased urinary zinc excretion, mediated by HPA axis disruption. Chronic corticosteroid use at doses above 2.5 mg/day can significantly lower plasma zinc levels. Zinc deficiency impairs immune function (paradoxically counteracting one purpose of immune-modulating corticosteroid therapy), delays wound healing, and contributes to taste disturbances and anorexia already common with corticosteroid use.
Recommendation: Consider zinc supplementation (15-30 mg/day) during chronic prednisone therapy, especially at doses >5 mg/day. Monitor zinc levels periodically. Pair zinc with copper supplementation (1-2 mg/day) to prevent copper depletion from chronic zinc use. Zinc supplementation may help offset immune suppression and support wound healing.
ModerateSynergy
Long-term prednisone therapy can cause rapid bone loss and increase fracture risk. Vitamin D2 can help maintain vitamin D status and calcium absorption as part of glucocorticoid-induced osteoporosis prevention.
Recommendation: Use vitamin D2 only as part of a complete bone-protection plan that includes calcium intake, vitamin D status monitoring, and fracture-risk assessment. If you are on prednisone for more than a short course, ask whether you need bone density testing or prescription osteoporosis prevention.
ModerateCaution
Prednisone can cause clinically important bone loss when used chronically. Strontium supplements may make DXA bone density results look higher because strontium in bone attenuates X-rays more than calcium, which can obscure whether steroid-induced bone loss is actually controlled.
Recommendation: Do not use strontium as a substitute for guideline-based prednisone bone protection. Tell your clinician and imaging center if you use strontium, especially before DXA testing, so bone density trends are interpreted cautiously.
NutriStack